Dawn Westrum’s Original Ivermectin Fact Sheet
The Fact Sheet identifies ivermectin as a broad-spectrum antiparasitic medicine with a long history of use for a variety of diseases. It notes that ivermectin was approved for human use in 1987 and names its use in tropical diseases such as onchocerciasis, lymphatic filariasis, strongyloidiasis, and scabies, as well as in animal parasite infestations.
Current Ivermectin Cancer Research
Current interest in ivermectin and cancer comes primarily from preclinical research — studies in cells and animals rather than completed evidence in people with cancer. A peer-reviewed review describes research into multiple potential tumor-related pathways, including multidrug resistance, Akt/mTOR, WNT-TCF, PAK-1, chloride channels, and cancer-stem-cell-like populations. Read the review in American Journal of Cancer Research.
That research landscape is why ivermectin has become part of broader cancer conversations. It is important to distinguish a promising pathway in a laboratory or animal model from an established human cancer treatment.
Human Cancer Studies
As of the trial record updated 15 July 2026, the University of Florida’s phase 2 ICONIC study (NCT07487805) is listed as not yet recruiting. It is designed to study intermediate- and high-dose ivermectin with immune-checkpoint inhibition in adults with solid tumors; no study results are posted. View the trial record on ClinicalTrials.gov.
The American Society of Clinical Oncology’s May 2026 clinical notice states that there is no robust peer-reviewed clinical evidence establishing ivermectin as safe or effective for treating any human malignancy outside a clinical trial. It also describes the early-study context, potential toxicity, and possible interaction considerations. Read ASCO’s clinical notice.
Cancer Education Series
- Part 1 — The Standard Model
- Part 2 — Shock, Stress & German New Medicine
- Part 3 — Voltage & Polarity
- Part 4 — Terrain, Immunity & Unwanted Growth
- Part 5 — Pulling the Thread Together
- Part 6 — Apricot Seeds & Vitamin B17
- You are here — Part 7 — Ivermectin & Cancer Research.
Questions and Answers
What kind of cancer research exists for ivermectin?
The linked review describes cell and animal research into multiple potential anticancer mechanisms. Those studies are preclinical and do not establish clinical benefit in people.
Is there a registered human cancer study?
Yes. ClinicalTrials.gov lists the University of Florida phase 2 ICONIC study as not yet recruiting, with no posted results as of its July 2026 update.
Does current research establish ivermectin as a cancer treatment?
No. The cited ASCO clinical notice says robust peer-reviewed clinical evidence has not established ivermectin as safe or effective for treating a human malignancy outside a clinical trial.